Atorvastatin attenuates coxsackie virus b3m-induced viral myocarditis in mice

Journal of Cardiovascular Pharmacology

Volumn 56, Issue 5, 2010, Pages 540-547

  Guan, Jian ^a   Sun, Xiaolu ^a   Liang, Yan ^a   Dong, Wei ^b   Zhang, Lianfeng ^b   Zhu, Jun ^a   Wang, Guogan ^a  

^a FUWAI HOSPITAL   (China)

^b INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

Author keywords

apoptosis; atorvastatin; Coxsackievirus B3m; Fas; myocarditis

Indexed keywords

ATORVASTATIN; FAS ANTIBODY; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; COXSACKIE VIRUS B3; DRUG EFFICACY; ECHOCARDIOGRAPHY; ENZYME BLOOD LEVEL; HEART MUSCLE CELL; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INOCULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TRANSMISSION ELECTRON MICROSCOPY; VIRUS MYOCARDITIS; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD95; APOPTOSIS; COXSACKIEVIRUS INFECTIONS; FAS LIGAND PROTEIN; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MICE; MYOCARDITIS; MYOCARDIUM; PYRROLES; RNA, MESSENGER; TROPONIN I;

EID: 78650170565     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181f6b28d     Document Type: Article

References (28)

1. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000;343: 1388-1398.
2. Lauer B, Schannwell M, Kuhl U, et al. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol. 2000;35: 11-18.
3. Crocker SJ, Frausto RF, Whitmire JK, et al. Amelioration of coxsack-ievirus B3-mediated myocarditis by inhibition of tissue inhibitors of matrix metalloproteinase-1. Am J Pathol. 2007;171:1762-1773.
4. Klingel K, Hohenadl C, Canu A, et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA. 1992;89:314-318.
5. Whitton JL. Immunopathology during coxsackievirus infection. Springer Semin Immunopathol. 2002;24:201-213.
6. Huber SA. Autoimmunity in coxsackievirus B3 induced myocarditis. Autoimmunity. 2006;39:55-61.
7. Seko Y, Kayagaki N, Seino K, et al. Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3. J Am Coll Cardiol. 2002;39:1399-1403.
8. Park DR, Thomsen AR, Frevert CW, et al. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and mono-cyte-derived macrophages. J Immunol. 2003;170:6209-6216.
9. Hohlbaum AM, Gregory MS, Ju ST, et al. Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J Immunol. 2001;167:6217-6224.
10. Cheng J, Zhou T, Liu C, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 1994;263:1759-1762.
11. Grundy SM. HMG-CoA reductase inhibitors for treatment of hypercho-lesterolemia. N Engl J Med. 1988;319:24-33.
12. Jasinska M, Owczarek J, Orszulak-Michalak D. Statins: a new insight into their mechanisms of action and consequent pleiotropic effects. Pharmacol Rep. 2007;59:483-499.
13. Tang Q, Huang J, Qian H, et al. Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is mediated by improving myocardial repolarization. Life Sci. 2007;80:601-608.
14. Woodruff JF. Viral myocarditis. A review. Am J Pathol. 1980;101:425-484.
15. Saraste A, Kytö V, Saraste M, et al. Coronary flow reserve and heart failure in experimental coxsackievirus myocarditis. A transthoracic Doppler echocardiography study. Am J Physiol Heart Circ Physiol. 2006;291: H871-H875.
16. Broberg CS, Pantely GA, Barber BJ, et al. Validation of the myocardial performance index by echocardiography in mice: a noninvasive measure of left ventricular function. J Am Soc Echocardiogr. 2003;16:814-823.
17. Heegaard AM, Corsi A, Danielsen CC, et al. Biglycan deficiency causes spontaneous aortic dissection and rupture in mice. Circulation. 2007;115: 2731-2738.
18. Niu J, Azfer A, Deucher MF, et al. Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1. J Mol Cell Cardiol. 2006;40:810-820.
19. Zhao L, Li S, Ge J, et al. Temporal changes in stem cells in the circulation and myocardium of mice with Coxsackie virus B3-induced myocarditis. Microvasc Res. 2008;75:358-366.
20. Saraste A, Arola A, Vuorinen T, et al. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis. Cardiovasc Pathol. 2003; 12:255-262.
21. Feuer R, Mena I, Pagarigan RR, et al. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol. 2003;163: 1379-1393.
22. Martin U, Nestler M, Munder T, et al. Characterization of coxsackievirus B3-caused apoptosis under in vitro conditions. Med Microbiol Immunol. 2004;193:133-139.
23. Carthy CM, Yanagawa B, Luo H, et al. Bcl-2 and Bcl-xL overexpression inhibits cytochrome c release, activation of multiple caspases, and virus release following coxsackievirus B3 infection. Virology. 2003;313: 147-157.
24. Henriques-Pons A, Oliveira GM, Paiva MM, et al. Evidence for a perforin-mediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection. Int J Exp Pathol. 2002;83:67-79.
25. Si X, Luo H, Morgan A, et al. Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release. J Virol. 2005;79:13875-13881.
26. Knowlton KU. CVB infection and mechanisms of viral cardiomyopathy. Curr Top Microbiol Immunol. 2008;323:315-335.
27. Lambert C, Landau AM, Desbarats J. Fas-beyond death: a regenerative role for Fas in the nervous system. Apoptosis. 2003;8:551-562.
28. Holler N, Tardivel A, Kovacsovics-Bankowski M, et al. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Mol Cell Biol. 2003;23:1428-1440.